Thin-Layer Radiochromatographic Determination of Captopril (SQ 14,225) and its Disulfide Dimer Metabolite in Blood
- 1 January 1980
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 3 (6) , 857-865
- https://doi.org/10.1080/01483918008060197
Abstract
A reliable thin-layer radiochromatographic (TLRC) assay has been developed for quantitation of radiolabeled captopril (CP), a new sulfhydryl-containing orally active antihypertensive agent, and its disulfide dimer metabolite (CPD) in blood. CP, which is chemically unstable in blood, was immediately converted to a stable derivative by addition of N-ethylmaleimide (NEM) to freshly collected samples. Aliquots of whole blood samples were analyzed for total radioactivity, and NEM-treated aliquots were extracted with methanol. Reconstituted residues of the extracts were applied to silica gel GF plates, developed with chloroform/ethyl acetate/glacial acetic acid (4:5:3), and analyzed for radioactivity associated with CP and CPD by zonal analysis.This publication has 5 references indexed in Scilit:
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- An improved scintillation cocktail of high-solubilizing powerAnalytical Biochemistry, 1973